Abstract
In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.
Schindler, Christoph; Birkenfeld, Andreas L; Hanefeld, Markolf; Schatz, Ulrike; Köhler, Carsta; Grüneberg, Martin; Tschöpe, Diethelm; Blüher, Matthias; Hasslacher, Christoph; Bornstein, Stefan R (2019). Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Therapy, 10(1):329-331.
Abstract
In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, not_refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Internal Medicine
Health Sciences > Endocrinology, Diabetes and Metabolism |
| Language: | English |
| Date: | February 2019 |
| Deposited On: | 01 Nov 2021 10:03 |
| Last Modified: | 27 Jan 2022 08:26 |
| Publisher: | Springer |
| ISSN: | 1869-6961 |
| OA Status: | Gold |
| Free access at: | PubMed ID. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1007/s13300-018-0546-6 |
| PubMed ID: | 30523582 |
Download
- Content: Published Version
- Licence:
Schindler, Christoph